These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1059 related articles for article (PubMed ID: 1657650)

  • 1. Breast carcinoma in situ in 167 women--incidence, mode of presentation, therapy and follow-up.
    Ringberg A; Andersson I; Aspegren K; Linell F
    Eur J Surg Oncol; 1991 Oct; 17(5):466-76. PubMed ID: 1657650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bilateral and multifocal breast carcinoma. A clinical and autopsy study with special emphasis on carcinoma in situ.
    Ringberg A; Palmer B; Linell F; Rychterova V; Ljungberg O
    Eur J Surg Oncol; 1991 Feb; 17(1):20-9. PubMed ID: 1847343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?
    Foster MC; Helvie MA; Gregory NE; Rebner M; Nees AV; Paramagul C
    Radiology; 2004 Jun; 231(3):813-9. PubMed ID: 15105449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lobular carcinoma in situ on core biopsy-what is the clinical significance?
    O'Driscoll D; Britton P; Bobrow L; Wishart GC; Sinnatamby R; Warren R
    Clin Radiol; 2001 Mar; 56(3):216-20. PubMed ID: 11247699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001.
    Li CI; Daling JR; Malone KE
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1008-11. PubMed ID: 15824180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast carcinoma-in-situ: an emerging problem in Singapore.
    Chua CL; Tan PK; Chiang G; Soo KC; Low CH
    Singapore Med J; 1992 Aug; 33(4):383-5. PubMed ID: 1329232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings].
    Piubello Q; Montemezzi S; D'Atri C
    Pathologica; 2002 Dec; 94(6):299-305. PubMed ID: 12540993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ carcinomas of the breast. Types, growth pattern, diagnosis, and treatment.
    Andersen J; Blichert-Toft M; Dyreborg U
    Eur J Surg Oncol; 1987 Apr; 13(2):105-11. PubMed ID: 3030823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nipple aspirate fluid cytology in breast carcinoma.
    Krishnamurthy S; Sneige N; Thompson PA; Marcy SM; Singletary SE; Cristofanilli M; Hunt KK; Kuerer HM
    Cancer; 2003 Apr; 99(2):97-104. PubMed ID: 12704689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge.
    Cabioglu N; Krishnamurthy S; Kuerer HM; Hunt KK; Singletary SE; Meric-Bernstam F; Ross MI; Feig BW; Ames FC; Babiera GV
    Cancer; 2004 Aug; 101(3):508-17. PubMed ID: 15274063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of 23,810 cases of ductal carcinoma-in-situ.
    Sumner WE; Koniaris LG; Snell SE; Spector S; Powell J; Avisar E; Moffat F; Livingstone AS; Franceschi D
    Ann Surg Oncol; 2007 May; 14(5):1638-43. PubMed ID: 17245612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In situ carcinomas of the breast: clinical features and therapeutic strategies].
    Attene F; Scognamillo F; Trignano E; Meloni GB; Rubino C; Trignano M
    Ann Ital Chir; 2006; 77(1):3-10; discussion 10-2. PubMed ID: 16910353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
    Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
    Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paget's disease of the nipple in a population based cohort.
    Dalberg K; Hellborg H; Wärnberg F
    Breast Cancer Res Treat; 2008 Sep; 111(2):313-9. PubMed ID: 17952590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lobular neoplasia at 11-gauge vacuum-assisted stereotactic biopsy: correlation with surgical excisional biopsy and mammographic follow-up.
    Mahoney MC; Robinson-Smith TM; Shaughnessy EA
    AJR Am J Roentgenol; 2006 Oct; 187(4):949-54. PubMed ID: 16985141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?
    Masood S; Loya A; Khalbuss W
    Diagn Cytopathol; 2003 Jun; 28(6):329-34. PubMed ID: 12768640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-year survival of 100 women with carcinoma of the breast diagnosed by screening mammography and needle-localization biopsy.
    Bauer TL; Pandelidis SM; Rhoads JE
    J Am Coll Surg; 1994 May; 178(5):427-30. PubMed ID: 8167877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy.
    Tunon-de-Lara C; Giard S; Buttarelli M; Blanchot J; Classe JM; Baron M; Monnier B; Houvenaeghel G
    Breast J; 2008; 14(2):135-40. PubMed ID: 18315691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.